These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 14954828)

  • 21. [ACTION OF ETHYBENZATROPINE ON EXTRAPYRAMIDAL SYNDROMES AND ABNORMAL MOVEMENTS].
    SIGWALD J; RAVERDY P; PIOT C
    Presse Med (1893); 1963 Dec; 71():2643-4. PubMed ID: 14102418
    [No Abstract]   [Full Text] [Related]  

  • 22. Functional state of basal ganglia in extrapyramidal and convulsive disorders; an electrographic study.
    SPIEGEL EA; WYCIS HT; BAIRD HW; SZEKELY EG
    AMA Arch Neurol Psychiatry; 1956 Feb; 75(2):167-74. PubMed ID: 13282536
    [No Abstract]   [Full Text] [Related]  

  • 23. [Stereotactic brain operations for the treatment of extrapyramidal movement disorders (parkinsonism and hyperkinesias) and their results].
    MUNDINGER F; RIECHERT T
    Fortschr Neurol Psychiatr Grenzgeb; 1963 Jan; 31():1-65 contd. PubMed ID: 13936606
    [No Abstract]   [Full Text] [Related]  

  • 24. Useful aids to stereotaxia and the surgical treatment of extrapyramidal disorders.
    NEGRIN J
    Confin Neurol; 1962; 22():332-5. PubMed ID: 13937933
    [No Abstract]   [Full Text] [Related]  

  • 25. [ELECTROMYOGRAPHIC ANALYSIS OF A SINGLE DOSE OF ORPHENADRINE HYDROCHLORIDE (DISIPAL) AND MEPROBAMATE ON POST-MEDICATION EXTRAPYRAMIDAL SYNDROME].
    ZAKRZEWSKA F; SUJECKA-SZYMKIEWICZ H; GRABOWSKI K
    Neurol Neurochir Psychiatr Pol; 1965; 15():107-13. PubMed ID: 14348655
    [No Abstract]   [Full Text] [Related]  

  • 26. [ELECTROMYOGRAPHIC ANALYSIS OF THE EFFECT OF A SINGLE DOSE OF TRIHEXYPHENIDYL AND IMIPRAMINE ON EXTRAPYRAMIDAL DISORDERS DIAGNOSED IN NEUROLEPTIC THERAPY].
    ZAKRZEWSKA F; SZYMKIEWICZ H; GRABOWSKI K
    Neurol Neurochir Psychiatr Pol; 1963; 13():687-93. PubMed ID: 14091517
    [No Abstract]   [Full Text] [Related]  

  • 27. [Extrapyramidal diseases].
    Satoyoshi E; Saku A
    Nihon Rinsho; 1971 Nov; 29(11):2462-8. PubMed ID: 5168795
    [No Abstract]   [Full Text] [Related]  

  • 28. Long term follow-up of results of stereotaxic treatment in extrapyramidal disorders.
    RIECHERT T
    Confin Neurol; 1962; 22():356-63. PubMed ID: 13982251
    [No Abstract]   [Full Text] [Related]  

  • 29. CAMPOTOMY IN VARIOUS EXTRAPYRAMIDAL DISORDERS.
    SPIEGEL EA; WYCIS HT; SZEKELY EG; ADAMS DJ; FLANAGAN M; BAIRD HW
    J Neurosurg; 1963 Oct; 20():871-84. PubMed ID: 14186082
    [No Abstract]   [Full Text] [Related]  

  • 30. [OBSERVATIONS ON 140 SCHIZOPHRENICS TREATED WITH FLUPHENAZINE. WITH SPECIAL REFERENCE TO DRUG-INDUCED EXTRAPYRAMIDAL SYNDROMES].
    KRUSE W
    Nervenarzt; 1963 Jun; 34():276-80. PubMed ID: 14160709
    [No Abstract]   [Full Text] [Related]  

  • 31. The extrapyramidal nervous system.
    Zaretsky S
    J Neurosurg Nurs; 1982 Dec; 14(6):295-8. PubMed ID: 6924687
    [No Abstract]   [Full Text] [Related]  

  • 32. Long-range effects of electropallidoansotomy in extrapyramidal and convulsive disorders.
    SPIEGEL EA; WYCIS HT; BAIRD HW
    Neurology; 1958 Oct; 8(10):734-40. PubMed ID: 13590379
    [No Abstract]   [Full Text] [Related]  

  • 33. [Lyseen (HH 212), a new substance for the treatment of extrapyramidal disorders and of muscle spasms of central and peripheral origin].
    SCHULZ HP
    Munch Med Wochenschr; 1961 May; 103():1066-8. PubMed ID: 13748916
    [No Abstract]   [Full Text] [Related]  

  • 34. [Experiences in the treatment of parkinsonism & other extrapyramidal disorders].
    KONIG JK
    Medizinische; 1959 Feb; 4(9):388-9. PubMed ID: 13643481
    [No Abstract]   [Full Text] [Related]  

  • 35. ELECTROPHYSIOLOGICAL STUDIES IN STEREOTAXIC SURGERY FOR EXTRAPYRAMIDAL DISORDERS. II. ELECTROPHYSIOLOGICAL STUDY OF GLOBUS PALLIDUS, THALAMUS AND THEIR VICINITY.
    JINNAI D; NISHIMOTO A; NUMOTO M; ADACHI I
    Confin Neurol; 1964; 24():281-8. PubMed ID: 14204908
    [No Abstract]   [Full Text] [Related]  

  • 36. [Present-day possibilities of relieving post-neuroleptic extrapyramidal symptoms].
    Wasik A
    Psychiatr Pol; 1973; 7(1):51-6. PubMed ID: 4715833
    [No Abstract]   [Full Text] [Related]  

  • 37. Neuropharmacology of the extrapyramidal system.
    Borison RL; Diamond BI
    J Clin Psychiatry; 1987 Sep; 48 Suppl():7-12. PubMed ID: 3305490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Late irreversible extrapyramidal syndrome following neuroleptic use].
    Boucebci M
    Acta Psychiatr Belg; 1972 Mar; 72(2):233-40. PubMed ID: 5056017
    [No Abstract]   [Full Text] [Related]  

  • 39. [Morpho-functional changes in the pyramidal and extrapyramidal systems due to triftazin].
    Krivitskaia GN; Sysoeva AF
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(7):1063-8. PubMed ID: 4627828
    [No Abstract]   [Full Text] [Related]  

  • 40. Drug-induced extrapyramidal disorders.
    Chase TN
    Res Publ Assoc Res Nerv Ment Dis; 1972; 50():448-71. PubMed ID: 4341954
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.